Global Hemp Group Inc. (GHG.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -24.79 Thousand CAD | -113.4% |
| 2022 | -893.58 Thousand CAD | 106.78% |
| 2021 | -7.81 Million CAD | -134.61% |
| 2020 | -870.04 Thousand CAD | 53.09% |
| 2019 | -2.95 Million CAD | -96.37% |
| 2018 | -1.21 Million CAD | -59.36% |
| 2017 | 700.00 CAD | -1101.36% |
| 2016 | - CAD | 79.0% |
| 2015 | -314.11 Thousand CAD | -105.0% |
| 2014 | - CAD | -177.11% |
| 2013 | -55.29 Thousand CAD | -60533.57% |
| 2012 | -91.20 CAD | 99.98% |
| 2011 | -396.18 Thousand CAD | 23.26% |
| 2010 | -516.3 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -60.37 Thousand CAD | 104.2% |
| 2024 Q3 | -82.01 Thousand CAD | 169.38% |
| 2024 Q2 | -71.66 Thousand CAD | -178.16% |
| 2023 Q2 | -116.54 Thousand CAD | -463.28% |
| 2023 Q3 | -90.17 Thousand CAD | 22.63% |
| 2023 Q4 | -354.74 Thousand CAD | -293.38% |
| 2023 FY | - CAD | -400.43% |
| 2023 Q1 | -20.69 Thousand CAD | -103.9% |
| 2022 Q3 | -195.01 Thousand CAD | -355.41% |
| 2022 Q1 | -20.5 Thousand CAD | 97.19% |
| 2022 FY | - CAD | 106.78% |
| 2022 Q2 | 76.35 Thousand CAD | 472.46% |
| 2022 Q4 | 529.9 Thousand CAD | 371.72% |
| 2021 Q2 | -1.02 Million CAD | -356.87% |
| 2021 FY | - CAD | -134.61% |
| 2021 Q3 | -747.55 Thousand CAD | 27.33% |
| 2021 Q4 | -728.5 Thousand CAD | 2.55% |
| 2021 Q1 | -225.15 Thousand CAD | -18199.36% |
| 2020 Q2 | -138.57 Thousand CAD | 86.0% |
| 2020 FY | - CAD | 53.09% |
| 2020 Q3 | -36.21 Thousand CAD | 73.87% |
| 2020 Q4 | 1244.00 CAD | 103.44% |
| 2020 Q1 | -990.01 Thousand CAD | -226.8% |
| 2019 Q1 | -3.1 Million CAD | -173.33% |
| 2019 FY | - CAD | -96.37% |
| 2019 Q2 | -141.86 Thousand CAD | 95.44% |
| 2019 Q3 | -14.27 Thousand CAD | 89.94% |
| 2019 Q4 | 780.8 Thousand CAD | 5571.24% |
| 2018 Q1 | -77.73 Thousand CAD | 89.63% |
| 2018 Q4 | -1.13 Million CAD | -596.1% |
| 2018 Q2 | -72.57 Thousand CAD | 6.65% |
| 2018 FY | - CAD | -59.36% |
| 2018 Q3 | -163.35 Thousand CAD | -125.08% |
| 2017 Q4 | -749.7 Thousand CAD | -6167.92% |
| 2017 Q2 | -22.5 Thousand CAD | -168.93% |
| 2017 Q1 | -8367.00 CAD | 56.57% |
| 2017 FY | - CAD | -1101.36% |
| 2017 Q3 | -11.96 Thousand CAD | 46.84% |
| 2016 Q4 | -19.26 Thousand CAD | -44.27% |
| 2016 Q3 | -13.35 Thousand CAD | 34.81% |
| 2016 Q1 | -12.86 Thousand CAD | 32.98% |
| 2016 Q2 | -20.48 Thousand CAD | -59.19% |
| 2016 FY | - CAD | 79.0% |
| 2015 FY | - CAD | -105.0% |
| 2015 Q4 | -19.2 Thousand CAD | 90.58% |
| 2015 Q3 | -203.92 Thousand CAD | -211.6% |
| 2015 Q2 | -65.44 Thousand CAD | -156.19% |
| 2015 Q1 | -25.54 Thousand CAD | 98.63% |
| 2014 Q2 | -407.34 Thousand CAD | -1221.86% |
| 2014 Q1 | -30.81 Thousand CAD | -38.96% |
| 2014 Q4 | -1.86 Million CAD | -385.43% |
| 2014 FY | - CAD | -177.11% |
| 2014 Q3 | -384.85 Thousand CAD | 5.52% |
| 2013 Q2 | -11.31 Thousand CAD | 19.02% |
| 2013 Q1 | -13.96 Thousand CAD | 46.88% |
| 2013 FY | - CAD | -60533.57% |
| 2013 Q3 | -18.75 Thousand CAD | -65.78% |
| 2013 Q4 | -22.17 Thousand CAD | -18.27% |
| 2012 Q3 | -15.44 Thousand CAD | 98.31% |
| 2012 Q1 | -30.11 Thousand CAD | 24.9% |
| 2012 Q2 | -911.84 Thousand CAD | -2927.69% |
| 2012 Q4 | -26.29 Thousand CAD | -70.28% |
| 2012 FY | - CAD | 99.98% |
| 2011 Q3 | -31.75 Thousand CAD | 18.79% |
| 2011 Q1 | -26.98 Thousand CAD | 0.0% |
| 2011 Q2 | -39.09 Thousand CAD | -44.88% |
| 2011 FY | - CAD | 23.26% |
| 2011 Q4 | -40.1 Thousand CAD | -26.31% |
| 2010 Q3 | -20.4 Thousand CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 99.592% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 98.767% |
| Blueberries Medical Corp. | -1.22 Million CAD | 97.971% |
| The BC Bud Corporation | -1.19 Million CAD | 97.927% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 99.618% |
| CordovaCann Corp. | -1.6 Million CAD | 98.453% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 99.055% |
| Captor Capital Corp. | 2.42 Million CAD | 101.024% |
| City View Green Holdings Inc. | -2.01 Million CAD | 98.769% |
| 1CM Inc. | 1.31 Million CAD | 101.888% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 98.877% |
| IM Cannabis Corp. | -2.79 Million CAD | 99.111% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 99.437% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 93.679% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 99.224% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 102.172% |
| Ovation Science Inc. | -778.83 Thousand CAD | 96.817% |
| Pharmadrug Inc. | -1.33 Million CAD | 98.143% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 99.591% |
| RAMM Pharma Corp. | -6.3 Million CAD | 99.607% |
| RIV Capital Inc. | -20.28 Million CAD | 99.878% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 99.557% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 99.968% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 99.16% |
| 1933 Industries Inc. | -10.03 Million CAD | 99.753% |
| Red Light Holland Corp. | -5.25 Million CAD | 99.528% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 96.772% |
| Xebra Brands Ltd. | -1.49 Million CAD | 98.342% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 98.243% |